- March 26, 2018
- Posted by: Neil Wilkie
- Category: Uncategorized
Mironid is delighted to announce the appointment of Prof Dorien Peters to our Scientific Advisory Board
Prof. Dr. Dorien Peters is a molecular geneticist and cellular biologist at the Leiden University Medical Center in the Netherlands. Her research aims to obtain insight into the genetic, pathophysiologic and functional mechanisms of inherited disorders, most notably Polycystic Kidney Disease (PKD), to design new therapeutic approaches. As part of her investigative portfolio, she has generated several informative and unique mouse models for PKD that are being used to perform an in-depth analysis of the molecular alterations, to identify new drug targets and test potential therapies.
To translate fundamental and preclinical research to the clinic she has organised a number of multidisciplinary research networks to enhance fundamental, pharmacologic and clinical insights into PKD. She was project leader of multidisciplinary TranCyst Marie-Curie training-network (2012-2016) and is coordinating the Dutch ‘Developing Interventions to hold Progression of Autosomal Dominant Polycystic Kidney Disease (DIPAK)’ consortium. She is an active (co)-organiser of international conferences (FASEB meeting on PKD 2011, 2014; EMBO Cilia meetings 2016 and 2018). She is member of the scientific board of the Dutch Federation of Nephrology (NFN), was member of the Scientific board of the Dutch Kidney Foundation (2011-2017) and member of the board of Dutch Society of Human Genetics (2000-2008).
Prof. Dr. Peters has published more than 120 scientific publications. In 2013 she received the Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease (PKD).